Clinical trial
Feasibility Study Through a Phase II Randomized Clinical Trial of an Intervention Based on Short Message System (SMS) to Promote Adherence to Antidiabetic Medication and Healthy Lifestyles in Patients With Type 2 Diabetes Mellitus
NCT04738591 is registered in ClinicalTrials.gov with Fundació d'investigació Sanitària de les Illes Balears as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study Through a Phase II Randomized Clinical Trial of an Intervention Based on Short Message System (SMS) to Promote Adherence to Antidiabetic Medication and Healthy Lifestyles in Patients With Type 2 Diabetes Mellitus
- Lead sponsor
- Fundació d'investigació Sanitària de les Illes Balears
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 30, 2020
- Completion date
- June 28, 2021
- Enrollment
- 207 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.